Novo Says May Take Years to Comply With FDA Request

Feb. 11 (Bloomberg) -- Novo Nordisk A/S Chief Executive Officer Lars Rebien Soerensen discusses the U.S. Food and Drug Administration's decision not to approve the insulin maker's Tresiba diabetes treatment, saying more data on heart safety is needed. He talks from Copenhagen with Francine Lacqua on Bloomberg Television's "On the Move." (Source: Bloomberg)

Remy Martin Sees Return of Chinese Consumer
52:53 - Cognac sales collapsed in China following the government's crackdown on extravagance in 2012, but French cognac maker Remy Martin is not giving up on the region. It has new tools, including a boutique in Beijing, that it says are already helping to ramp up sales, especially at the high-end. Remy Martin Chief Executive Officer Eric Vallat spoke with Bloomberg's Ramy Inocencio about his ambitions in China. (Source: Bloomberg)
  • Legere: AT&T, Time Warner Deal Is a 'Diversion Tactic'
  • Hello World Japan: The Future Looks Like a Drunk Robot
  • T-Mobile CEO Sees Benefits of Deal-Distracted AT&T